These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 11091769)

  • 21. Summaries for patients. Adherence to nonnucleoside reverse transcriptase inhibitor-based HIV therapy and patient outcomes.
    Ann Intern Med; 2007 Apr; 146(8):I28. PubMed ID: 17438312
    [No Abstract]   [Full Text] [Related]  

  • 22. Current developments in anti-HIV/AIDS gene therapy.
    Tsygankov AY
    Curr Opin Investig Drugs; 2009 Feb; 10(2):137-49. PubMed ID: 19197791
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adherence to antiretroviral therapy in pediatric patients with human immunodeficiency virus (HIV-1).
    Burack G; Gaur S; Marone R; Petrova A
    J Pediatr Nurs; 2010 Dec; 25(6):500-4. PubMed ID: 21035017
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adherence to highly active antiretroviral therapy.
    Zuger A
    AIDS Clin Care; 1997 Nov; 9(11):86-7. PubMed ID: 11364775
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antiretroviral therapy: toxicity and adherence.
    Nadkar MY; Bajpai S
    J Assoc Physicians India; 2009 May; 57():375-6. PubMed ID: 19634282
    [No Abstract]   [Full Text] [Related]  

  • 26. The role of depression in predicting antiretroviral adherence in Ugandan parents and their children initiating HAART in the MTCT-plus family treatment model: commentary on Jayne Byakika-Tusiime et al. 2009.
    Nakimuli-Mpungu E; Musisi S
    AIDS Behav; 2009 Oct; 13(5):969-72. PubMed ID: 19662522
    [No Abstract]   [Full Text] [Related]  

  • 27. [Which antiretroviral strategy to use in adults?].
    Tonnerre P
    Rev Infirm; 2003 Sep; (93):12-6. PubMed ID: 14593983
    [No Abstract]   [Full Text] [Related]  

  • 28. Adherence to antiretroviral therapy in pregnancy.
    Kingston MA; Letham CJ; McQuillan O
    Int J STD AIDS; 2007 Nov; 18(11):787-9. PubMed ID: 18005515
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Study on adherence and interrelated factors of acquired immunedeficiency syndrome patients receiving antiretroviral treatment].
    Li H; Wang Z; Cui WG; Liang Y; Xin TY; Li J
    Zhonghua Liu Xing Bing Xue Za Zhi; 2005 Jul; 26(7):507-10. PubMed ID: 16335002
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Challenges of adherence management in human immunodeficiency virus pharmacotherapy.
    Park-Wyllie LY; Phillips EJ
    Can J Clin Pharmacol; 2003; 10(4):189-95. PubMed ID: 14712324
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Effective, safe and simple. The future means "once daily"].
    MMW Fortschr Med; 2002 Apr; 144 Suppl 1():40-4. PubMed ID: 12043073
    [No Abstract]   [Full Text] [Related]  

  • 32. Highly active antiretroviral treatment in countries with very limited resources: do we have cheaper alternatives?
    Colebunders R; Florence E; Lynen L; Bouckenooghe A
    Int J STD AIDS; 2003 Jan; 14(1):1-5. PubMed ID: 12590784
    [No Abstract]   [Full Text] [Related]  

  • 33. [Psychological variables and adherence to antiretroviral treatment].
    Gordillo Alvarez-Valdés MV; González-Lahoz J
    An Med Interna; 2000 Jan; 17(1):38-41. PubMed ID: 10730405
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The good, the bad, and the ugly: providing highly active antiretroviral therapy when it is most difficult.
    Flanigan TP; Mitty JA
    Clin Infect Dis; 2006 Jun; 42(11):1636-8. PubMed ID: 16652322
    [No Abstract]   [Full Text] [Related]  

  • 35. A programmable prompting device improves adherence to highly active antiretroviral therapy in HIV-infected subjects with memory impairment.
    Andrade AS; McGruder HF; Wu AW; Celano SA; Skolasky RL; Selnes OA; Huang IC; McArthur JC
    Clin Infect Dis; 2005 Sep; 41(6):875-82. PubMed ID: 16107989
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Influencing medication adherence among women with AIDS.
    Jones DL; Ishii M; LaPerriere A; Stanley H; Antoni M; Ironson G; Schneiderman N; Van Splunteren F; Cassells A; Alexander K; Gousse YP; Vaughn A; Brondolo E; Tobin JN; Weiss SM
    AIDS Care; 2003 Aug; 15(4):463-74. PubMed ID: 14509861
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Predicting and monitoring antiretroviral adherence.
    Gross R
    LDI Issue Brief; 2007; 13(2):1-4. PubMed ID: 18354853
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Initial antiretroviral drugs.
    Rojo P; Gonzalez-Tome MI; Ramos JT
    Pediatr Infect Dis J; 2007 Dec; 26(12):1167; author reply 1167. PubMed ID: 18043466
    [No Abstract]   [Full Text] [Related]  

  • 39. Adherence to HAART: perspectives from clients in treatment support programs.
    Weiss L; French T; Waters M; Netherland J; Agins B; Finkelstein R
    Psychol Health Med; 2006 May; 11(2):155-70. PubMed ID: 17129905
    [TBL] [Abstract][Full Text] [Related]  

  • 40. AIDS care: adhering to antiretroviral therapy.
    Brummet L
    Nurs BC; 2002 Oct; 34(4):24-5. PubMed ID: 12448910
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.